IFP Advisors, Inc - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 74 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$11,000
-54.2%
8,255
+50.1%
0.00%0.0%
Q2 2018$24,000
+50.0%
5,500
+59.2%
0.00%0.0%
Q1 2018$16,0000.0%3,4550.0%0.00%0.0%
Q4 2017$16,000
-48.4%
3,455
-38.0%
0.00%0.0%
Q3 2017$31,000
+93.8%
5,575
+106.5%
0.00%0.0%
Q2 2017$16,000
+300.0%
2,700
+285.7%
0.00%
Q1 2017$4,000
-50.0%
700
-56.2%
0.00%
Q4 2016$8,000
+700.0%
1,600
+128.6%
0.00%
Q3 2016$1,0000.0%7000.0%0.00%
Q2 2016$1,000
-50.0%
7000.0%0.00%
Q4 2015$2,0007000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders